Pharma Marketing Talk is hosted by John Mack, the creator of Pharma Marketing Blog and Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
About Pharma Marketing Talk | List of Shows | Schedule and Archives | FAQs
Side Effects: Death
If you cannot make the live podcast, an audio archive is available after the show. Click on a button below to listen to the streaming audio archive on your computer or to download the archived show for playback on your iPod or other portal audio player.
Last year Virapen published a fictional novel (written in German) about corruption in the pharma industry, which created some debate. He was urged by the public to tell the true story and has now written a book of memoirs primarily outlining the criminal activities he was involved in during his active years.
The Big Fish here is Eli Lilly. A few months ago Virapen was invited by Andy Vickery, a prominent US attorney, as a fact witness in an ongoing case regarding Prozac. Virapen claims to have "damning evidence" exposing Eli Lilly bribing the regulatory board in Sweden to attain marketing approval for Prozac.
In this podcast, Virapen will reveal some of the details of this ongoing expose that few in the US are aware of.
Additional Resources
A Former Lilly Insider Blows the Whistle on Criminal Activity in Sweden
John Virapen, an ex-Eli-Lilly-executive and author of the book "Side Effect: Death" (published in Sweden and Germany)
MP3 Audio File for your iPOD (Archive available 30 minutes after the show).
WMA Audio File for Windows Media Player and other audio players (Archive available 30 minutes after the show).
WAX Audio File for Windows Media Player (Archive available 30 minutes after the show).
Background
John Virapen is now retired, after working more than 30 years in the pharma industry internationally. He haas worked at the executive level for some major companies such as Eli Lilly and Novo Nordisk. His career started in Sweden where he was Managing Director for Eli Lilly Sweden AB. Virapen now lives in Germany.